Unraveling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma (TASMA) Extension Study
Unraveling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma (TASMA) Extension Study
This study evaluates the longterm clinical outcomes, including safety and efficacy parameters
 after Bronchial Thermoplasty (BT) treatment over a period of 5 years. All patients included
 in de TASMA trial in the Netherlands will be asked to participate in the TASMA extension
 study.
Inclusion Criteria:

 -  Subject participation in the TASMA study

 -  Ability and willingness to provide informed consent.

 -  Ability to comply with the study protocol

 Exclusion Criteria:

 -  Subject participating in another clinical trial involving respiratory intervention
 which in the opinion of the investigator might interfere with the study.